Review article: Ulcerative colitis, smoking and nicotine therapy

Area of Science:

• Gastroenterology
• Environmental Medicine
• Pharmacology

Background:

• Smoking is a significant environmental factor associated with ulcerative colitis (UC).
• Smoking demonstrates a protective effect on both the onset and progression of UC.
• The precise mechanisms underlying smoking's influence on UC remain under investigation.

Purpose of the Study:

• To investigate the relationship between UC and smoking.
• To explore potential pathogenic mechanisms involved.
• To evaluate nicotine's efficacy as a therapeutic agent for UC.

Main Methods:

• A comprehensive literature search was performed using MEDLINE.
• MeSH terms included 'ulcerative colitis,' 'smoking,' and 'nicotine.'
• Relevant articles were identified through manual review and reference list screening.

Main Results:

• Ulcerative colitis is less common in smokers, who often experience milder disease compared to ex-smokers and non-smokers.
• Evidence is conflicting regarding reduced hospitalizations, colectomies, and need for corticosteroids or immunosuppressants in smokers.
• Nicotine showed variable efficacy in inducing UC remission, with significant adverse events limiting its use.

Conclusions:

• Nicotine's therapeutic application for ulcerative colitis is restricted, potentially useful only in select refractory cases.
• The study questions whether nicotine is the primary component in smoking responsible for modifying UC risk and inflammation.
• Further research is needed to elucidate the exact role of smoking and its components in UC pathogenesis and treatment.